JAK2 and breast carcinoma: We also demonstrated the essentiality of its catalytic activity in suppressing breast cancer lung metastasis, as evidenced by the observation that PTPRO with an active site mutation failed not only to dephosphorylate JAK2 and YAP but also to inhibit breast cancer lung metastasis.